HUP0202042A3 - Use of insulin for preparing of pharmaceutical composition for decreasing fasting sugars and weight gains in diabetic patients - Google Patents
Use of insulin for preparing of pharmaceutical composition for decreasing fasting sugars and weight gains in diabetic patientsInfo
- Publication number
- HUP0202042A3 HUP0202042A3 HU0202042A HUP0202042A HUP0202042A3 HU P0202042 A3 HUP0202042 A3 HU P0202042A3 HU 0202042 A HU0202042 A HU 0202042A HU P0202042 A HUP0202042 A HU P0202042A HU P0202042 A3 HUP0202042 A3 HU P0202042A3
- Authority
- HU
- Hungary
- Prior art keywords
- insulin
- preparing
- pharmaceutical composition
- diabetic patients
- weight gains
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 208000021017 Weight Gain Diseases 0.000 title 1
- 230000003247 decreasing effect Effects 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 235000000346 sugar Nutrition 0.000 title 1
- 150000008163 sugars Chemical class 0.000 title 1
- 230000004584 weight gain Effects 0.000 title 1
- 235000019786 weight gain Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30004901P | 2001-06-21 | 2001-06-21 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU0202042D0 HU0202042D0 (enExample) | 2002-08-28 |
| HUP0202042A2 HUP0202042A2 (hu) | 2004-05-28 |
| HUP0202042A3 true HUP0202042A3 (en) | 2004-06-28 |
Family
ID=23157477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202042A HUP0202042A3 (en) | 2001-06-21 | 2002-06-20 | Use of insulin for preparing of pharmaceutical composition for decreasing fasting sugars and weight gains in diabetic patients |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20030079747A1 (enExample) |
| EP (1) | EP1270012A1 (enExample) |
| JP (1) | JP2003012543A (enExample) |
| KR (1) | KR20020097033A (enExample) |
| CN (1) | CN1289143C (enExample) |
| AU (1) | AU4884102A (enExample) |
| CA (1) | CA2390757A1 (enExample) |
| CZ (1) | CZ20022151A3 (enExample) |
| HK (1) | HK1049617B (enExample) |
| HU (1) | HUP0202042A3 (enExample) |
| IL (1) | IL150209A0 (enExample) |
| NZ (1) | NZ519403A (enExample) |
| PL (1) | PL354641A1 (enExample) |
| SK (1) | SK9042002A3 (enExample) |
| ZA (1) | ZA200204859B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004054606A1 (en) * | 2002-12-13 | 2004-07-01 | Pfizer Products Inc. | Method of decreasing hepatic glucose output in diabetic patients |
| KR20060015469A (ko) * | 2003-03-04 | 2006-02-17 | 더 테크놀로지 디벨로프먼트 컴퍼니 리미티드 | 경구용 인슐린 조성물 및 그 제조방법 및 사용방법 |
| CA2631493A1 (en) * | 2005-12-15 | 2007-06-21 | Acusphere, Inc. | Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration |
| WO2008118387A2 (en) * | 2007-03-23 | 2008-10-02 | Wayne State University | Erythrocyte atp-release modulators |
| EP2060268A1 (en) * | 2007-11-15 | 2009-05-20 | Novo Nordisk A/S | Pharmaceutical compositions for pulmonary or nasal delivery of peptides |
| BR112012001271A2 (pt) * | 2009-07-22 | 2016-02-10 | Lilly Co Eli | método para a previsão de ganho de peso associado com uma terapia farmacêutica |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5230884A (en) * | 1990-09-11 | 1993-07-27 | University Of Wales College Of Cardiff | Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations |
| DK10191D0 (da) * | 1991-01-22 | 1991-01-22 | Novo Nordisk As | Hidtil ukendte peptider |
| CA2112674C (en) * | 1991-07-02 | 2005-10-04 | John S. Patton | Method and device for delivering aerosolized medicaments |
| US5320094A (en) * | 1992-01-10 | 1994-06-14 | The Johns Hopkins University | Method of administering insulin |
| US5785049A (en) * | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| US6024090A (en) * | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
| US5743250A (en) * | 1993-01-29 | 1998-04-28 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
| US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| ATE264096T1 (de) * | 1994-03-07 | 2004-04-15 | Nektar Therapeutics | Verfahren und mittel zur verabreichung von insulin über die lunge |
| CZ289029B6 (cs) * | 1994-09-21 | 2001-10-17 | Inhale Therapeutic Systems | Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu |
| US5898028A (en) * | 1997-03-20 | 1999-04-27 | Novo Nordisk A/S | Method for producing powder formulation comprising an insulin |
| DE19733651A1 (de) * | 1997-08-04 | 1999-02-18 | Boehringer Ingelheim Pharma | Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole |
| PL197504B1 (pl) * | 1998-10-16 | 2008-04-30 | Novo Nordisk As | Trwałe stężone preparaty insulinowe do podawania do płuc |
| JP2002543092A (ja) * | 1999-04-27 | 2002-12-17 | イーライ・リリー・アンド・カンパニー | 肺投与用インスリン結晶 |
| WO2001000674A1 (en) * | 1999-06-29 | 2001-01-04 | Eli Lilly And Company | Insulin crystals for pulmonary administration |
| US7060675B2 (en) * | 2001-02-15 | 2006-06-13 | Nobex Corporation | Methods of treating diabetes mellitus |
| WO2002080935A1 (en) * | 2001-04-04 | 2002-10-17 | Ortho Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| MY137181A (en) * | 2001-05-21 | 2009-01-30 | Nektar Therapeutics | Pulmonary administration of chemically modified insulin |
-
2002
- 2002-06-06 NZ NZ519403A patent/NZ519403A/en unknown
- 2002-06-06 EP EP02253950A patent/EP1270012A1/en not_active Ceased
- 2002-06-12 IL IL15020902A patent/IL150209A0/xx unknown
- 2002-06-17 CA CA002390757A patent/CA2390757A1/en not_active Abandoned
- 2002-06-18 ZA ZA200204859A patent/ZA200204859B/xx unknown
- 2002-06-19 US US10/176,146 patent/US20030079747A1/en not_active Abandoned
- 2002-06-19 CZ CZ20022151A patent/CZ20022151A3/cs unknown
- 2002-06-19 AU AU48841/02A patent/AU4884102A/en not_active Abandoned
- 2002-06-20 PL PL02354641A patent/PL354641A1/xx not_active Application Discontinuation
- 2002-06-20 HU HU0202042A patent/HUP0202042A3/hu unknown
- 2002-06-20 JP JP2002179903A patent/JP2003012543A/ja not_active Revoked
- 2002-06-21 KR KR1020020034812A patent/KR20020097033A/ko not_active Ceased
- 2002-06-21 SK SK904-2002A patent/SK9042002A3/sk unknown
- 2002-06-21 CN CNB02124880XA patent/CN1289143C/zh not_active Expired - Fee Related
-
2003
- 2003-03-08 HK HK03101700.6A patent/HK1049617B/zh not_active IP Right Cessation
-
2005
- 2005-05-27 US US11/140,052 patent/US20050220722A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1393265A (zh) | 2003-01-29 |
| EP1270012A1 (en) | 2003-01-02 |
| HU0202042D0 (enExample) | 2002-08-28 |
| JP2003012543A (ja) | 2003-01-15 |
| KR20020097033A (ko) | 2002-12-31 |
| HK1049617B (zh) | 2007-03-16 |
| IL150209A0 (en) | 2002-12-01 |
| CN1289143C (zh) | 2006-12-13 |
| HUP0202042A2 (hu) | 2004-05-28 |
| CA2390757A1 (en) | 2002-12-21 |
| US20030079747A1 (en) | 2003-05-01 |
| HK1049617A1 (en) | 2003-05-23 |
| CZ20022151A3 (cs) | 2003-04-16 |
| NZ519403A (en) | 2005-03-24 |
| PL354641A1 (en) | 2002-12-30 |
| AU4884102A (en) | 2003-01-02 |
| SK9042002A3 (en) | 2003-05-02 |
| ZA200204859B (en) | 2004-01-28 |
| US20050220722A1 (en) | 2005-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101293A3 (en) | Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use | |
| IL171683A (en) | Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment | |
| HUP0204574A3 (en) | Propionic acid derivatives and their use in the treatment of diabetes and obesity, pharmaceutical compositions containing them and their preparation | |
| IL162143A0 (en) | Pharmaceutical compositions comprising metformine and glibenclamide for treatment of type-II diabetes mellitus | |
| AU2001279593A1 (en) | A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome | |
| HUP0301212A3 (en) | Use of glucagon-like peptide-1 analogs for preparation pharmaceutical compositions and for treating diabetes | |
| AU2003230985A1 (en) | Method and composition for preventing pain in sickle cell patients | |
| IL158862A0 (en) | An insulin composition for pulmonary administration | |
| AU2003295614A1 (en) | Delivery of pharmaceutical agents via the human insulin receptor | |
| PL393259A1 (pl) | Mimetyki trombopoetyny, kompozycje farmaceutyczne je zawierające, zastosowanie tych związków do wytwarzania leków, sposoby wytwarzania związków, kompozycji, sposób poprawy stymulacji dojrzewania megakariocytów, sposób poprawy przeżywalności i/lub proliferacji komórek oraz związki pośrednie | |
| IL183982A0 (en) | Controlled release formulation for oral administration for treating diabetes containing metformin and methods for the preparation thereof | |
| HUP0202338A3 (en) | Pharmaceutical composition containing fenofibrate and preparation method | |
| IL162765A (en) | Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use | |
| PL370554A1 (en) | New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
| WO2000041504A3 (en) | Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides | |
| HUP0202042A3 (en) | Use of insulin for preparing of pharmaceutical composition for decreasing fasting sugars and weight gains in diabetic patients | |
| IL180900A0 (en) | Immunogenic complexes, preparation method thereof and use of same in pharmaceutical compositions | |
| IL149360A0 (en) | Method and compositions for administering taxanes orally to human patients | |
| IL158794A0 (en) | The use of adenosine and analogues for producing medicines for the treatment of the insulin resistance syndrome and diabetes | |
| HUP0500958A2 (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them | |
| AU2001243369A1 (en) | Composition and method to treat weight gain and obesity attributable to psychotropic drugs | |
| HUP0201810A3 (en) | Sootepenseone and its derivatives, their preparation and use as medicament | |
| EP1583545A4 (en) | PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF PEPTIDES OF HIV GP41 AND ITS THERAPEUTIC USE | |
| AU2003281176A1 (en) | Medicinal composition for mitigating blood lipid or lowering blood homocystein | |
| PL369632A1 (en) | Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |